Challenge
As Xeris Pharmaceuticals prepared to go public and brought its first FDA-approved product to market, the company faced rising complexity in managing its contract portfolio. With contracts stored in shared drives and tracked manually, the team lacked visibility, control, and audit-readiness. Rapid employee growth and strict compliance requirements—such as those mandated by the Sunshine Act and Insider Trading regulations—further heightened the need for a more robust, centralized contract management solution.